The endocrine system and ageing

Journal of Pathology

Volumn 211, Issue 2, 2007, Pages 173-180

  Chahal, H S ^a   Drake, W M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Adrenal; Ageing; Dehydroepiandrosterone; Endocrine; Follicle stimulating hormone; Growth hormone; Luteinizing hormone; Oestrogen; Testosterone; Thyroid

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CONJUGATED ESTROGEN; CORTICOTROPIN; DEXAMETHASONE; ESTROGEN; FOLLITROPIN; GESTAGEN; GROWTH HORMONE DERIVATIVE; LUTEINIZING HORMONE; PLACEBO; PRASTERONE; RALOXIFENE; RECOMBINANT GROWTH HORMONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE;

ADRENAL DISEASE; AGING; ANDROPAUSE; ANEMIA; ARTHRALGIA; BODY FAT; BONE MASS; BREAST CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARPAL TUNNEL SYNDROME; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; ENDOCRINE DISEASE; ERECTILE DYSFUNCTION; ESTROGEN THERAPY; FATIGUE; GERIATRIC DISORDER; GROWTH HORMONE DEFICIENCY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; HYPERGLYCEMIA; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; IMMUNOPATHOLOGY; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LEAN BODY WEIGHT; LIBIDO DISORDER; LOW DRUG DOSE; LUNG EMBOLISM; MENOPAUSAL SYNDROME; MONOTHERAPY; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; THROMBOEMBOLISM; THYROID DISEASE; VASOMOTOR DISORDER; VEIN THROMBOSIS;

AGING; ANDROGENS; DEHYDROEPIANDROSTERONE; ENDOCRINE SYSTEM; FEMALE; GONADOTROPINS, PITUITARY; HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MENOPAUSE; PARATHYROID HORMONE; PITUITARY-ADRENAL SYSTEM; SOMATOMEDINS; THYROID GLAND;

EID: 33846663572     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2110     Document Type: Review

References (86)

1. Johnson SR. Menopause and hormone replacement therapy. Med Clin North Am 1998;82(2):297-320.
2. Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976;42(4):629-636.
3. Longcope C, Jaffee W, Griffing G. Metabolic clearance rates of androgens and oestrogens in ageing women. Maturitas 1980;2(4):283-290.
4. Speroff L, Glass RH, Kase NG (eds). Clinical Gynecologic Endocrinology and Infertility (6th edn). Lippincott Williams and Wilkins: Baltimore, MD, 1999.
5. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;17(3):321-333.
6. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/ progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280(7):605-613.
7. Riggs BL, Melton LJI. Involutional osteoporosis. N Engl J Med 1986;314(26):1676-1686.
8. Nordin BE, Wishart JM, Clifton PM, McArthur R, Scopacasa F, Need AG, et al. A longitudinal study of bone-related biochemical changes at the menopause. Clin Endocrinol (Oxf) 2004;61(1):123-130.
9. Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med 1987;317(19):1169-1174.
10. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995;333(22):1437-1443.
11. Delmas PD, Bjarnason NH, Mitlak BH, Ravonx AC, Shah AS, Huster WJ, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337(23):1641-1647.
12. ACOG Task Force on Hormone Therapy. Obstetrics and Gynecology 2004;104(S4):112S.
13. Hammar M, Christau S, Nathorst-Boos J, Rud T, Garre K. A double-blind, randomized trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998;105(8):904-911.
14. Shaywitz SE, Shaywitz BA, Pugh KR, Fulbright RK, Skudlarski P, Menci WE, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. J Am Med Assoc 1999;281(13):1197-1202.
15. Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, et al. Effects of estrogen with and without progestin on urinary incontinence. J Am Med Assoc 2005;293(8):935-948.
16. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343(10):682-688.
17. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2004;291(14):1701-1712.
18. Shumaker SA, Legault C, Kuller L, Rapp SR, Thai L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. J Am Med Assoc 2004;291(24):2947-2958.
19. Crawford F, Langhorne P. Time to review all the evidence for hormone replacement therapy. Br Med J 2005;330(7487):345.
20. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73(5):1016-1025.
21. Morley JE, Kaiser FE, Perry HMI, Patrick P, Morley PM, Stauber PM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997;46(4):410-413.
22. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86(2):724-731.
23. Vermeulen A. Androgen replacement therapy in the aging male - a critical evaluation. J Clin Endocrinol Metab 2001;86(6):2380-2390.
24. Ishimaru T, Pages L, Horton R. Altered metabolism of androgens in elderly men with benign prostatic hyperplasia. J Clin Endocrinol Metab 1977;45(4):695-701.
25. Mulligan T, Iranmanesh A, Johnson ML, Straume M, Veldhuis JD. Aging alters feed-forward and feedback linkages between LH and testosterone in healthy men. Am J Physiol 1997;273(4, pt 2):R1407-1413.
26. Mitchell R, Hollis S, Rothwell C, Robertson WR. Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive. Clin Endocrinol (Oxf) 1995;42(5):501-507.
27. Veldhuis JD, Zwart A, Mulligan T, Iranmanesh A. Muting of androgen negative feedback unveils impoverished gonadotropin-releasing hormone/ luteinizing hormone secretory reactivity in healthy older men. J Clin Endocrinol Metab 2001;86(2):529-535.
28. Harman SM, Tsitouras PD. Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab 1980;51(1):35-40.
29. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983;56(6):1278-1281.
30. Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM. Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 2002;87(10):4522-4527.
31. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002;87(8):3632-3639.
32. Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 2005;63(3):280-293.
33. Tenover JL. Testosterone and the aging male. J Androl 1997;18(2):103-106.
34. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14(1):20-39.
35. Brook CG, Hindmarsh PC. The somatotropic axis in puberty. Endocrinol Metab Clin North Am 1992;21(4):767-782.
36. Veldhuis JD, Iranmanesh A, Bowers CY. Joint mechanisms of impaired growth-hormone pulse renewal in aging men. J Clin Endocrinol Metab 2005;9(7):4177-4183.
37. Sonntag WE, Forman LJ, Miki N, Trapp JM, Gottschall PE, Meites J. L-Dopa restores amplitude of growth hormone pulses in old male rats to that observed in young male rats. Neuroendocrinology 1982;34(3):163-168.
38. Takahashi S, Gottschall PE, Quigley KL, Goya RG, Meites J. Growth hormone secretory patterns in young, middle-aged and old female rats. Neuroendocrinology 1987;46(2):137-142.
39. Dobado-Berrios PM, Ruiz-Navarro A, Almaden Y, Malagon MM, Garrido JC, Ramirez-Gutierrez JL, et al. Heterogeneity of growth hormone (GH)-producing cells in aging male rats: ultrastructure and GH gene expression in somatotrope subpopulations. Mol Cell Endocrinol 1996;118(1-2):181-191.
40. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab 1993;76(1):134-138.
41. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab 1992;75(2):530-535.
42. Chapman IM, Hartman ML, Pezzoli SS, Thorner MO. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults - a clinical research center study. J Clin Endocrinol Metab 1996;81(8):2874-2880.
43. Russell-Aulet M, Jaffe CA, Mott-Friberg R, Barkan AL. In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging. J Clin Endocrinol Metab 1999;84(10):3490-3497.
44. Vahl N, Jorgensen JO, Jurik AG, Christiansen JS. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab 1996;81(6):2209-2215.
45. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998;83(2):382-395.
46. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323(1):1-6.
47. Vance ML. Can growth hormone prevent aging? N Engl J Med 2003;348(9):779-780.
48. Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. J Am Med Assoc 2002;288(18):2282-2292.
49. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996;124(8):708-716.
50. Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 1994;79(5):1361-1366.
51. Brill KT, Weltman AL, Gentili A, Patrie JT, Fryburg DA, Hanks JB, et al. Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J Clin Endocrinol Metab 2002;87(12):5649-5657.
52. Giannoulis MG, Sonksen PH, Umpleby M, Breen L, Pentecost C, Whyte M, et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab 2006;91(2):477-484.
53. Mariotti S, Franceschi C, Cossarizza A, Pinchera A. The aging thyroid. Endocr Rev 1995;16(6):686-715.
54. Oddie TH, Meade JH Jr, Fisher DA. An analysis of published data on thyroxine turnover in human subjects. J Clin Endocrinol Metab 1966;26(4):425-436.
55. Olsen T, Laurberg P, Weeke J. Low serum triiodothyronine and high serum reverse triiodothyronine in old age: an effect of disease not age. J Clin Endocrinol Metab 1978;47(5):1111-1115.
56. Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med 1991;151(1):165-168.
57. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331(19):1249-1252.
58. Mariotti S, Barbesino G, Caturegli P, Bartalena L, Sansoni P, Fagnoni F, et al. Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab 1993;77(5):1130-1134.
59. Cuttelod S, Lemarchand-Beraud T, Magnenat P, Perret C, Poli S, Vannotti A. Effect of age and role of kidneys and liver on thyrotropin turnover in man. Metabolism 1974;23(2):101-113.
60. Greenspan SL, Klibanski A, Rowe JW, Elahi D. Age-related alterations in pulsatile secretion of TSH: role of dopaminergic regulation. Am J Physiol 1991;260(3 Pt 1):E486-491.
61. Chiovato L, Mariotti S, Pinchera A. Thyroid diseases in the elderly. Baillières Clin Endocrinol Metab 1997;11(2):251-270.
62. Pinchera A, Mariotti S, Barbesino G, Bechi R, Sansoni P, Fagiolo U, et al. Thyroid autoimmunity and ageing. Horm Res 1995;43(1-3):64-68.
63. Bergendahl M, Iranmanesh A, Mulligan T, Veldhuis JD. Impact of age on cortisol secretory dynamics basally and as driven by nutrient-withdrawal stress. J Clin Endocrinol Metab 2000;85(6):2203-2214.
64. Parker CR Jr, Slayden SM, Azziz R, Crabbe SL, Hines GA, Boots LR, et al. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000;85(1):48-54.
65. Waltman C, Blackman MR, Chrousos GP, Riemann C, Harman SM. Spontaneous and glucocorticoid-inhibited adrenocorticotropic hormone and cortisol secretion are similar in healthy young and old men. J Clin Endocrinol Metab 1991;73(3):495-502.
66. Van CE, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996;81(7):2468-2473.
67. Sherman B, Wysham C, Pfohl B. Age-related changes in the circadian rhythm of plasma cortisol in man. J Clin Endocrinol Metab 1985;61(3):439-443.
68. Laughlin GA, Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85(10):3561-3568.
69. Seeman TE, Robbins RJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 1994;15(2):233-260.
70. Seeman TE, McEwen BS, Singer BH, Albert MS, Rowe JW. Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. J Clin Endocrinol Metab 1997;82(8):2458-2465.
71. Dennison E, Hindmarsh P, Fall C, Kellingray S, Barker D, Phillips D, et al. Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab 1999;84(9):3058-3063.
72. Greendale GA, Unger JB, Rowe JW, Seeman TE. The relation between cortisol excretion and fractures in healthy older people: results from the MacArthur studies. J Am Geriatr Soc 1999;47(7):799-803.
73. Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab 2004;89(1):281-287.
74. Yen SS, Laughlin GA. Aging and the adrenal cortex. Exp Gerontol 1998;33(7-8):897-910.
75. Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metab 1996;81(9):3147-3157.
76. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59(3):551-555.
77. Labile F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82(8):2396-2402.
78. Vermeulen A. Dehydroepiandrosterone sulfate and aging. Ann N Y Acad Sci 1995;774:121-127.
79. Parker CR Jr, Mixon RL, Bilssie RM, Grizzle WE. Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 1997;82(11):3898-3901.
80. Allolio B, Arlt W. DHEA treatment: myth or reality? Trends Endocrinol Metab 2002;13(7):288-294.
81. Gurnell EM, Chatterjee VK. Dehydroepiandrosterone replacement therapy. Eur J Endocrinol 2001;145(2):103-106.
82. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78(6):1360-1367.
83. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA 2000;97(8):4279-4284.
84. Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendorfer RA, et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 1997;82(7):2363-2367.
85. Arlt W, Callies F, Koehler I, van Vlijmen JC, Fassnacht M, Strasburger CJ, et al. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. J Clin Endocrinol Metab 2001;86(10):4686-4692.
86. Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, Allen S, Krause G. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 1999;84(5):1527-1533.